Literature DB >> 30626666

RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon Element.

Zhe Wen1, Chunchen Wu2, Xinwen Chen3,4, Yongxuan Yao1,5, Bo Yang1,5, Yingshan Chen4,6, Hui Wang4,6, Xue Hu4, Yuan Zhou4, Xiuzhu Gao7, Mengji Lu4,8, Junqi Niu7.   

Abstract

Encapsidation of pregenomic RNA (pgRNA) is a crucial step in hepatitis B virus (HBV) replication. Binding by viral polymerase (Pol) to the epsilon stem-loop (ε) on the 5'-terminal region (TR) of pgRNA is required for pgRNA packaging. However, the detailed mechanism is not well understood. RNA-binding motif protein 24 (RBM24) inhibits core translation by binding to the 5'-TR of pgRNA. Here, we demonstrate that RBM24 is also involved in pgRNA packaging. RBM24 directly binds to the lower bulge of ε via RNA recognition submotifs (RNPs). RBM24 also interacts with Pol in an RNA-independent manner. The alanine-rich domain (ARD) of RBM24 and the reverse transcriptase (RT) domain of Pol are essential for binding between RBM24 and Pol. In addition, overexpression of RBM24 increases Pol-ε interaction, whereas RBM24 knockdown decreases the interaction. RBM24 was able to rescue binding between ε and mutant Pol lacking ε-binding activity, further showing that RBM24 mediates the interaction between Pol and ε by forming a Pol-RBM24-ε complex. Finally, RBM24 significantly promotes the packaging efficiency of pgRNA. In conclusion, RBM24 mediates Pol-ε interaction and formation of a Pol-RBM24-ε complex, which inhibits translation of pgRNA and results in pgRNA packing into capsids/virions for reverse transcription and DNA synthesis.IMPORTANCE Hepatitis B virus (HBV) is a ubiquitous human pathogen, and HBV infection is a major global health burden. Chronic HBV infection is associated with the development of liver diseases, including fulminant hepatitis, hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. A currently approved vaccine can prevent HBV infection, and medications are able to reduce viral loads and prevent liver disease progression. However, current treatments rarely achieve a cure for chronic infection. Thus, it is important to gain insight into the mechanisms of HBV replication. In this study, we found that the host factor RBM24 is involved in pregenomic RNA (pgRNA) packaging and regulates HBV replication. These findings highlight a potential target for antiviral therapeutics of HBV infection.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HBV epsilon element; HBV polymerase; RBM24; interaction; pgRNA packaging

Mesh:

Substances:

Year:  2019        PMID: 30626666      PMCID: PMC6401439          DOI: 10.1128/JVI.02161-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Identification of an essential molecular contact point on the duck hepatitis B virus reverse transcriptase.

Authors:  Feng Cao; Matthew P Badtke; Lisa M Metzger; Ermei Yao; Babatunde Adeyemo; Yunhao Gong; John E Tavis
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA.

Authors:  J K Jeong; G S Yoon; W S Ryu
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.

Authors:  Haifeng Wang; Seahee Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation.

Authors:  Seahee Kim; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 8.  Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention.

Authors:  Scott A Jones; Jianming Hu
Journal:  Emerg Microbes Infect       Date:  2013-09-04       Impact factor: 7.163

9.  Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.

Authors:  Vyas Ramanan; Kartik Trehan; Mei-Lyn Ong; Joseph M Luna; Hans-Heinrich Hoffmann; Christine Espiritu; Timothy P Sheahan; Hamsika Chandrasekar; Robert E Schwartz; Kathleen S Christine; Charles M Rice; Alexander van Oudenaarden; Sangeeta N Bhatia
Journal:  Virology       Date:  2016-04-27       Impact factor: 3.616

10.  RNA binding protein 24 regulates the translation and replication of hepatitis C virus.

Authors:  Huang Cao; Kaitao Zhao; Yongxuan Yao; Jing Guo; Xiaoxiao Gao; Qi Yang; Min Guo; Wandi Zhu; Yun Wang; Chunchen Wu; Jizheng Chen; Yuan Zhou; Xue Hu; Mengji Lu; Xinwen Chen; Rongjuan Pei
Journal:  Protein Cell       Date:  2018-01-30       Impact factor: 14.870

View more
  7 in total

1.  Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle.

Authors:  Aurélie Schnuriger; Patrick Soussan; Jules Sotty; Pierre Bablon; Bouchra Lekbaby; Jérémy Augustin; Morgane Girier-Dufournier; Lucas Langlois; Céline Dorival; Fabrice Carrat; Stanislas Pol; Hélène Fontaine; Nazim Sarica; Christine Neuveut; Chantal Housset; Dina Kremdsorf
Journal:  Hepatol Int       Date:  2022-08-04       Impact factor: 9.029

Review 2.  Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA.

Authors:  Claryssa Bianca; Elizabeth Sidhartha; Claudio Tiribelli; Korri Elvanita El-Khobar; Caecilia H C Sukowati
Journal:  World J Hepatol       Date:  2022-05-27

Review 3.  Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target.

Authors:  Timothy S Buhlig; Anastasia F Bowersox; Daniel L Braun; Desiree N Owsley; Kortney D James; Alfredo J Aranda; Connor D Kendrick; Nicole A Skalka; Daniel N Clark
Journal:  Viruses       Date:  2020-05-22       Impact factor: 5.048

Review 4.  RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity?

Authors:  De-Li Shi
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

5.  RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.

Authors:  Richeng Mao; Minhui Dong; Zhongliang Shen; Hu Zhang; Yuanjie Liu; Dawei Cai; Bidisha Mitra; Jiming Zhang; Haitao Guo
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

Review 6.  RNA-Binding Protein Rbm24 as a Multifaceted Post-Transcriptional Regulator of Embryonic Lineage Differentiation and Cellular Homeostasis.

Authors:  Raphaëlle Grifone; Ming Shao; Audrey Saquet; De-Li Shi
Journal:  Cells       Date:  2020-08-12       Impact factor: 6.600

Review 7.  Pathogenicity and virulence of Hepatitis B virus.

Authors:  Yu-Chen Chuang; Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.